ProThera Biologics Competitors and Similar CompaniesClear all
ProThera Biologics's competitors and similar companies include GBT (Global Blood Therapeutics), Travere Therapeutics, Heron Therapeutics and Camurus.
 GBT (Global Blood Therapeutics) GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. |  Travere Therapeutics Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases. |  Heron Therapeutics Heron Therapeutics (formerly A.P. Pharma) is a biotechnology company engaged in drug discovery and development. |  Camurus Camurus is a research-based pharmaceutical company that develops medicines for severe and chronic conditions. | ||
Founding Date | Founding Date 2001 | Founding Date 2012 | Founding Date 2011 | Founding Date 1983 | Founding Date 1991 |
Type | Type Private | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Providence, US HQ | Locations South San Francisco, US HQ Paris, FR Berlin, DE Baar, CH London, GB | Locations San Diego, US HQ Dublin, IE | Locations San Diego, US HQ | Locations Lund, SE HQ Sydney, AU Mannheim, DE Duxford, GB |
Employees | Employees 5 | Employees 352106% increase | Employees 46293% increase | Employees 20333% decrease | Employees 265 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 4.4 b | Valuation ($) 1.4 b | Valuation ($) 268.5 m | Valuation ($) 3.4 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $194.7m (FY, 2021) | Revenue (est.) $490.7m (FY, 2025) | Revenue (est.) $154.9m (FY, 2025) | Revenue (est.) kr2.3b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $3.3m (FY, 2021) | Cost of goods $10.3m (FY, 2025) | Cost of goods $41.3m (FY, 2025) | Cost of goods kr138.7m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $480.4m (FY, 2025) | Gross profit $113.6m (FY, 2025) | Gross profit kr2.1b (FY, 2025) |
Net income | Net income N/A | Net income ($303.1m) (FY, 2021) | Net income ($25.5m) (FY, 2025) | Net income ($20.2m) (FY, 2025) | Net income kr735.6m (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 750k | Total funding raised $ 88.7m | Total funding raised $ 25m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
GBT (Global Blood Therapeutics)
HQ
South San Francisco, US
Employees
352
GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.
View companyTravere Therapeutics
HQ
San Diego, US
Employees
462
Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.
View companyHeron Therapeutics
HQ
San Diego, US
Employees
203↓ 33% decrease
Heron Therapeutics (formerly A.P. Pharma) is a biotechnology company engaged in drug discovery and development.
View companyCamurus
HQ
Lund, SE
Employees
265
Camurus is a research-based pharmaceutical company that develops medicines for severe and chronic conditions.
View company